
New terminology for haematuria and its diagnosis
Terminology
- Visible haematuria—replaces macroscopic and gross haematuria
- Non-visible haematuria—replaces microscopic and dipstick positive haematuria
- Symptomatic non-visible haematuria—non-visible haematuria plus lower urinary tract symptoms (hesitancy, frequency, urgency, dysuria) or upper urinary tract symptoms
- Asymptomatic non-visible haematuria—incidental detection of non-visible haematuria in the absence of upper or lower urinary tract symptoms
Diagnosis of haematuria
- Exclude transient causes, such as urinary tract infection, before further assessment
- A urine dipstick test for blood is generally sufficient. It is sensitive when performed on fresh voided urine with no preservatives. A score of ≥1+ is positive; a trace amount is considered negative
- A positive result for haemolysed red blood cells should be treated the same as for non-haemolysed red cells
- Further assessment is warranted in patients with urinary tract symptoms and non-visible haematuria and a score of ≥1+ on a single blood dipstick test
- In patients with asymptomatic non-visible haematuria confirm persistence of blood in at least two out of three dipstick tests
- It is not necessary to confirm the dipstick result by microscopy
Causes of transient or spurious non-visible haematuria
- Transient
- Urinary tract infection
- Exercise related
- Spurious
- Menstrual contamination
- Sexual intercourse
- Foods such as beetroot, blackberries, and rhubarb
- Rhabdomyolysis
- Drugs such as doxorubicin, chloroquine, and rifampicin
- Chronic lead or mercury poisoning
Causes of persistent non-visible haematuria
- Urological causes
- Common
- Benign prostatic hyperplasia
- Cancer (bladder, kidney, prostate, ureter)
- Calculus disease or nephrolithiasis
- Cystitis or pyelonephritis
- Prostatitis or urethritis
- Schistosoma haematobium infection
- Less common
- Radiation cystitis
- Urethral strictures
- Tuberculosis
- Medullary sponge kidney
- Cyclophosphamide induced cystitis
- Rare
- Arteriovenous malformation
- Renal artery thrombosis
- Polycystic kidney disease
- Papillary necrosis of any cause
- Loin pain haematuria syndrome
- Common
- Nephrological causes
- Common
- IgA nephropathy (Berger’s disease)
- Thin basement membrane disease
- Less common
- Acute glomerular disease:
- Postinfectious glomerulonephritis
- Rapidly progressive glomerulonephritis
- Systemic lupus nephritis
- Vasculitis
- Goodpasture’s disease
- Henoch-Schönlein purpura syndrome
- Haemolytic-uraemic syndrome
- Chronic primary glomerulonephritis:
- Focal segmental glomerulonephritis
- Mesangio-capillary glomerulonephritis
- Membranous nephropathy
- Mesangial proliferative glomerulonephritis
- Familial causes:
- Polycystic kidney disease (autosomal dominant or recessive)
- Hereditary nephritis (Alport’s syndrome)
- Fabry’s disease
- Nail-patella syndrome
- Acute glomerular disease:
- Common
Investigations
- MSU
- Plasma creatinine and estimated glomerular filtration rate
- Measure proteinuria—send a random sample of urine for protein:creatinine ratio or albumin:creatinine ratio (according to local practice). Twenty four hour urine collections for protein are rarely needed—24 hour urine protein or albumin excretion (in mg) can be approximated by multiplying the ratio (in mg/mmol) by 10
- Measure blood pressure
Referral
- All patients with visible or non-visible haematuria who have urinary tract symptoms should be referred for urological assessment
- Patients aged ≥40 with asymptomatic non-visible haematuria should be referred for urological assessment
- Patients under 40 with asymptomatic non-visible haematuria need urological assessment only if the estimated glomerular filtration rate is reduced (<60 ml/min) or proteinuria is >0.5 g/d
- Patients with no abnormal findings on urological assessment need long term observation, usually in primary care. Patients should be reassessed if they develop visible haematuria or urinary tract symptoms. Nephrology assessment is recommended for falling renal function or new or increasing proteinuria
Assessment and management of non-visible haematuria in primary care BMJ 2009
10-Minute Consultation: haematuria